Bartter syndrome: Unraveling the pathophysiologic enigma

American Journal of Medicine

Volumn 105, Issue 2, 1998, Pages 151-161

  Guay Woodford, Lisa M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; DIURETIC AGENT; INDOMETACIN; MAGNESIUM; POTASSIUM CHLORIDE; SPIRONOLACTONE; TRIAMTERENE;

BARTTER SYNDROME; DIFFERENTIAL DIAGNOSIS; FAMILIAL DISEASE; GITELMAN SYNDROME; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0032144244     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00196-X     Document Type: Article

References (105)

1. 1. Rosenbaum P, Hughes M. Persistent, probably congenital hypokalemic metabolic alkalosis with hyaline degeneration of renal tubules and normal urinary aldosterone. Am J Dis Child. 1957;94: 560.
2. 2. Pronove P, MacCardle R, Bartter F. Aldosteronism, hypokalemia, and a unique renal lesion in a five year old boy. Acta Endocrinol. 1960;(suppl 51):167-168.
3. 3. Bartter F, Pronove P, J Gill J, MacCardle R. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med. 1962;33:811-828.
4. 4. Gitelman H, Graham J, Welt L. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:221-235.
5. 5. Rudin A. Bartter's syndrome - a review of 28 patients followed for 10 years. Acta Med Scand. 1988;224:165-171.
6. 6. Camacho T, Blizzard R. Congenital hypokalemia of probable renal origin. Am J Dis Child. 1962;103:535-554.
7. 7. Dillon M, Shah V, Mitchel N. Bartter's syndrome: ten cases in childhood. Quart J Med. 1979;191:429-446.
8. 8. Hogewind B, Van Brummelen P, Veltkamp J. Bartter's syndrome: an autosomal recessive disorder? Study of four patients in one generation of the same pedigree and their relatives. Acta Med Scand. 1981;209:463-67.
9. 9. Pereira R, Werch JV. Inheritance of Bartter's syndrome. Am J Med Genet. 1983;15:79-84.
10. 10. Crowe P, Ahmad A, O'Byrne K, Cullen M. Bartter's syndrome in two generations of an Irish family. Postgrad Med J. 1993;69:791-796.
11. 11. Smilde T, Haverman J, Schipper P, et al. Familial hypokalemia/ hypomagnesemia and chondrocalcinosis. J Rheumatol. 1994;21: 1515-1519.
12. 12. Bettinelli A, Bianchetti M, Borella P, et al. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalciuria (Gitelman's syndrome). Kidney Int. 1995;47:547-551.
13. 13. Gitelman H. Hypokalemia, hypomagnesemia, and alkalosis: a rose is a rose - or is it? J Pediat. 1992;129:79-80.
14. 14. Bettinelli A, Bianchetti M, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemia alkalosis: Bartter and Gitelman syndromes. J Pediat. 1992;120:38-43.
15. 15. Gladziwa U, Schwarz R, Gitter A, et al. Chronic hypokalaemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare. Nephrol Dial Transplant. 1995;10:1607-1613.
16. 16. Robson WL, Arbus GS, Balfe IW. Bartter's syndrome. Differentiation into two clinical groups. Am J Dis Child. 1979;133:636-638.
17. 17. Clive D. Bartter's syndrome: the unsolved puzzle. Am J Kid Dis. 1995;25:813-823.
18. 18. Schwartz I, Alon U. Bartter syndrome revisited. J Nephrol. 1996;9: 81-87.
19. 19. Simopoulos A. Growth characteristics in patients with Bartter's syndrome. Nephron. 1979;23:130-135.
20. 20. Marco-Franco IA, Morey CV, Gasco J, Alacron A. Long-term evolution and growth patterns in a family with Bartter syndrome. Clin Nephrol. 1994;42:33-37.
21. 21. Dunn M. Prostaglandins and Bartter's syndrome. Kidney Int. 1981;18:86-102.
22. 22. Gill JR. Bartter's syndrome. Annu Rev Med. 1980;31:405-19.
23. 23. Stein JH. The pathogenetic spectrum of Bartter's syndrome. Kidney Int. 1985;28:85-93.
24. 24. O'Regan S, Rivard G, Mongreau J-G, Robitaille P. A circulating inhibitor of platelet aggregation in Bartter's syndrome. Pediatrics. 1979;64:939-941.
25. 25. Pierratos A, Couture R, Hierlihy P, et al. Bartter's syndrome, nephrocalcinosis and renal insufficiency. Can Med Assoc J. 1989; 141:1055-1057.
26. 26. Arant B, Brackett N, Young R, Still W. Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal ricketts-Bartter's syndrome or disease. Pediatrics. 1970;46:344-361.
27. 27. Tolins J, Hostetter M, Hostetter T. Hypokalemic nephropathy in the rat: role of ammonia in chronic tubular injury. J Clin Invest. 1987;79:1447-1458.
28. 28. Geven W, Willems J, Schroder C, Monnens L. Study of the pathophysiology of Bartter/Gitelman's syndrome. Magnesium Bull. 1994;16:29-36.
29. 29. Bianchetti M, Bettinelli A, Casez J, et al. Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman syndrome. J Clin Endocrinol Metab. 1995;80:224-228.
30. 30. Luthy C, Bettinelli A, Iselin S, et al. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter syndrome. Am J Kid Dis. 1995;25:824-828.
31. 31. Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M. Hypomagnesemia of hereditary renal origin. Pediatr Nephrol. 1987;1:465-472.
32. 32. McCredie D. Variants of Bartter's syndrome. Pediatr Nephrol. 1996;10:419-421.
33. 33. Saeed M, Al-Gambi M, Cameron E, Sutton R. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kid Dis. 1994;24:737-752.
34. 34. Colussi G, Macaluso M, Brunati C, Minetti L. Calcium metabolism and calciotrpic hormone levels in Gitelman's syndrome. Miner Electrolyte Metab. 1994;20:294-301.
35. 35. Ohlsson A, Sieck U, Cumming W, et al. Bartter syndrome associated with hydraamnios, prematurity, hypercalciuria and nephrocalcinosis. Acta Pediat Scand. 1984;73:868-874.
36. 36. Proesmans W, Devlieger H, Assche AV, et al. Bartter syndrome in two siblings - antenatal and neonatal observations. Int J Pediat Nephrol. 1985;6:63-70.
37. 37. Seyberth HW, Rascher W, Schweer H, et al. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter's syndrome. J Pediatr. 1985;107:694-701.
38. 38. Seyberth H, Koniger S, Rascher W, et al. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol. 1987;1:491-497.
39. 39. Proesmans W, Massa G, Vanderberghe K, Assche AV. Prenatal diagnosis in Bartter syndrome. Lancet. I:394.
40. 40. Leonhardt A, Timmermanns G, Roth B, Seyberth H. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr. 1992;120:546-554.
41. 41. Simon D, Karet F, Hamdan J, et al. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genetics. 1996;13:183-188.
42. 42. Simon D, Karet F, Hamdan J, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nature Genetics. 1996;14:152-156.
43. 43. The International Collaborative Study Group for Bartter-like Syndromes. Mutations in the gene encoding the inwardly rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. Hum Mol Genet. 1997;6:17-26.
44. 44. Landau D, Shalev H, Ohaly M, Carmi R. Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Gene. 1995;59:454-459.
45. 45. Landau D, Shalev H, Brennan T, et al. Mapping of an infantile variant of Bartter syndrome to chromosome 1. J Am Soc Nephrol. 1996;7:1838A.
46. 46. James T, Holland N, Preston D. Bartter syndrome: typical facies and normal plasma volume. Am J Dis Child. 1975;129:1205-1207.
47. 47. Madrigal G, Saborio P, Mora F, et al. Bartter syndrome in Costa Rica: a description of twenty cases. Pediatr Nephrol. 1997;11:296-301.
48. 48. Kennedy J, Dinwiddie R, Daman-Willems C, et al. Pseudo-Bartter's syndrome in cystic fibrosis. Arch Dis Child. 1990;65:786-787.
49. 49. Grossman H, Duggan E, McCamman S, et al. The dietary chloride deficiency syndrome. Pediatrics. 1980;66:366-374.
50. 50. Rosenblum M, Simpson D, Evenson M. Factious Bartter's syndrome. Arch Intern Med. 1977;137:1244-1245.
51. 51. Cremer W, Block K. Syndrome and course of chronic hypokalemic nephropathy in man. Clin Nephrol. 1977;7:112-119.
52. 52. Bartter F. On the pathogenesis of Bartter syndrome. Miner Electrolyte Metab. 1980;3:61-65.
53. 53. Gans R, Hoorntje S. Bartter's syndrome. In Cameron S, Davison A, Grunfeld J, et al, eds. Oxford Textbook of Clinical Nephrology. New York: Oxford University Press; 1992:782-789.
54. 54. Gordon J, Stokes J. Understanding and treating Bartter syndrome. Hosp Pract. 1994;29:103-110.
55. 55. Fujita T, Ano K, Sato T, et al. Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter syndrome. Am J Med. 1982;73:71-76.
56. 56. Radfar N, Gill G, Bravo E, et al. Hypokalemia in Bartter's syndrome and other disorders produces resistance to vasopressors vis prostaglandin overproduction. Proc Soc Exp Biol Med. 1978;158: 502-507.
57. 57. Stahl M, Vaara I, Hedner P, Ekman R. Vasoactive peptides in Bartter's syndrome. Eur J Clin Invest. 1993;23:80-83.
58. 58. Fujita T, Sakaguchi H, Shibagaki M, et al. The pathogenesis of Bartter's syndrome. Functional and histologic studies. Am J Med. 1977;63:467-474.
59. 59. Sasaki H, Okamura M, Asano T, et al. Responses to angiotensin II before and after treatment with indomethacin in Bartter's syndrome. BMJ. 1977;2:995-996.
60. 60. Silverberg A, Mennes P, Cryer P. Resistance to endogenous norepinephrine in Bartter's syndrome. Revision during indometacin administration. Am J Med. 1978;64:231-235.
61. 61. Sasaki H, Okumura M, Ikeda M, et al. Hypotensive response to angiotensin II analogue in Bartter's syndrome. NEJM. 1976;294: 611-612.
62. 62. Yoshida H, Kakuchi J, Yoshikawa N, et al. Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome. Kidney Int. 1994;46:1505-1509.
63. 63. Bourke E, Delaney V. Bartter's syndrome - a dilemma of cause and effect. Nephron. 1981;27:177-186.
64. 64. Schlondorff D, Ardaillou R. Prostaglandins and other arachicondic acid metabolites in the kidney. Kidney Int. 1986;29:108-119.
65. 65. Gill J, Bartter FC. Evidence for a prostaglandin independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome. Am J Med. 1978;65:766-772.
66. 66. Greger R, Heidland A. Action and clinical use of diuretics. In: Cameron S, Davison AM, Grufeld JP, eds. Textbook of Clinical Nephrology. London: Oxford University Press; 1991:197-223.
67. 67. Cogan M, Rector F. Acid-base disorders. In Brenner B, Rector IFC, eds. The Kidney. 4th ed. Philadelphia: WB Saunders; 1991:776-777.
68. 68. Boer W, Hene R, Koomans H, Mees ED. Discrepancy between lithium and free water clearance in patients with Bartter syndrome. Nephron. 1994;67:82-87.
69. 69. Hufnagle K, Khan S, Penn D, et al. Renal calcifications: a complication of long-term furosemide therapy in pre-term infants. Pediatrics. 1982;70:360-363.
70. 70. Venkataraman, Han B, Tsang R, Daugerthy C. Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide RX. J Pediatr Adolesc Med (Am J Dis Child). 1983;137: 1157-1161.
71. 71. Kockerling A, Reinalter S, Seyberth H. Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. J Pediatr. 1996;129:519-528.
72. 72. Simon D, Lifton R. The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndromes. Am J Physiol. 1996; 271:F961-F966.
73. 73. Simon D, Nelson-Williams C, Bia M, et al. Gitelman's variant of Bartter syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nature Genetics. 1996;12:24-30.
74. 74. Greger R. Ion transport mechanism in thick ascending limb of Henle's loop of mammalian nephron. Physiol Rev. 1985;65:760-797.
75. 75. Greger R. Chloride transport in thick ascending limb, distal convolution and collecting duct. Annu Rev Physiol. 1988;50:111-122.
76. 76. Brunette M, Mailloux J, Lajeunesse D. Calcium transport through the luminal membrane of the distal tubule: I. Interrelationship with sodium. Kidney Int. 1992;41:281-288.
77. 77. de Rouffignac C, Quame G. Renal magnesium handling and its hormonal control. Physiol Rev. 1994;74:305-322.
78. 78. Zusman R, Keiser H. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Clin Invest. 1977;60:215-223.
79. 79. Zusman R, Keiser H. Regulation of prostaglandin E2 synthesis by angiotensin II, potassium, osmolality, and dexamethasone. Kidney Int. 1980;19:277-283.
80. 80. Nivet H, Grenier B, Rolland J, et al. Raised urinary prostaglandins in patient without Bartter's syndrome. Lancet. 1978;1:333-334.
81. 81. Mayatepek E, Seyberth H, Nutzenadel W. Effects of indomethacin in congenital chloride diarrhea. J Pediatr Gastroenterol Nutr. 1992; 14:319-322.
82. 82. Stokes J. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest. 1979;64: 495-502.
83. 83. Culpepper R, Andreoli T. Interactions among prostaglandin E2, antidiuretic hormone and cyclic adenosine monophosphate in modulating CI absorption in single mouse medullary thick ascending limbs of Henle. J Clin Invest. 1983;71:1588-1591.
84. 84. Wang W-H. Two types of K+ channel in thick ascending limb of rat kidney. Am J Physiol. 1994;267:F599-F605.
85. 85. Macica C, Yang Y, Hebert S. Arachidonic acid inhibits activity of the cloned renal K channel, ROMK1. Am J Physiol. 1996;271: F588-F594.
86. 86. Sutton R, Mavichak V, Halabe A, Wilkins G. Bartter's syndrome: evidence suggesting a distal tubular defect in a hypocalciuric variant of the syndrome. Miner Electrolyte Metab. 1992;18:43-51.
87. 87. Gamba G, Saltzberg S, Lombari M, et al. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Nat Acad Sci USA. 1993;90:2749-2753.
88. 88. Gamba G, Miyanoshita A, Lombardi M, et al. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem. 1994;269: 17713-17722.
89. 89. Karolyi L, Ziegler A, Pollak M, et al. Gitelman's syndrome is genetically distinct from other forms of Bartter syndrome. Pediatr Nephrol. 1996;10:551-554.
90. 90. Lemmink H, Heuvel Lvd, Dijk Hv, et al. Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatr Nephrol. 1996;10:403-407.
91. 91. Pollak M, Delaney V, Graham R, Hebert S. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred. J Am Soc Nephrol 1996;7:2244-2248.
92. 92. Gesek F, Friedman P. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest. 1992;90:429-438.
93. 93. Fanconi A, Schachenmann G, Nussli R, Prader A. Chronic hypokalemia with growth retardation, normotensive hyperrenin-hyperaldosteronism ("Bartter's syndrome") and hypercalciuria. Helv Pediatr Acta. 1971;2:144-163.
94. 94. Al-Ghambi S, Cameron E, Sutton R. Magnesium deficiency: pathophysiology and clinical overview. Am J Kid Dis. 1994;24: 737-752.
95. 95. Sano M, Shichiri M, Ida T, et al. Pathophysiologic role of magnesium in familial Bartter's syndrome. Intern Med. 1994;33:1-5.
96. 96. Seidel C, Reinalter S, Seyberth H, Scharer K. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol. 1995;9: 723-728.
97. 97. Nakao A, Allen M, Sonnenburg W, Smith W. Regulation of cAMP metabolism by PGE2 in cortical and medullary thick ascending limbs of Henle's loop. Am J Physiol. 1989;256:C652-C657.
98. 98. Hene R, Koomans H, Boer P, Mees ED. Long-term treatment of Bartter's syndrome with captopril. BMJ. 1982;285:695.
99. 99. James J, Davies D. The use of captopril in Bartter's syndrome. BMJ. 1984;289:162.
100. 100. Scherling B, Verder H, Nielson M. Captopril treatment in Bartter's syndrome. Scand J Urol Nephrol. 1990;214:123-125.
101. 101. Cunningham R, Brouhard B, Berger M, et al. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome. Pediatrics. 1979;63:754-756.
102. 102. Delpire E, Kaplan M, Plotkin M, Hebert S. TheNa-(K)-Cl cotransporter family in the mammalian kidney: molecular identification and functions. Nephrol Dial Transplant. 1996;11:1967-1973.
103. 103. Giebisch G, Wang W. Potassium transport: from clearance to channels to pumps. Kidney Int. 1996;49:1624-1631.
104. 104. Hebert S. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int. 1996; 50:2129-2139.
105. 105. Toh H, Ichikawa A, Narumiva S. Molecular evolution of receptors for eicosanoids. FEBS Lett. 1995;361:17-21.